Dolasetron is a 5-hydroxytryptamine antagonist active at type 111 receptors; it is presently undergoing clinical evaluation for the reduction/prevention of cancer chemotherapyinduced nausea and vomiting. Following intravenous administration to healthy male subjects of doses ranging from 0.6 to 5 mg
Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration
β Scribed by Lawrence T. Sennello; Richard A. Finley; Sou-Yie Chu; Cheryl Jagst; Devorah Max; Douglas E. Rollins; Keith G. Tolman
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 359 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of progesterone were characterized in ovariectomized female rats. Progesterone was administered intravenously at a dose of 500 pg kg-'. Serum progesterone concentrations were determined by radioimmunoassay. Serum concentrations of progesterone were best described by a two-compar
## Abstract Pharmacokinetic and bioavailability parameters of propranolol were estimated in 10 healthy adult subjects after single oral doses of two commercial tablet formulations of propranolol hydrochloride (2 Γ 40 mg). Plasma concentrations of propranolol were determined by a highβperformance li
## Abstract Dolasetron is a 5βhydroxytryptamine antagonist active at type III receptors; it is presently undergoing clinical evaluation for the reduction/prevention of cancer chemotherapyinduced nausea and vomiting. A previous study demonstrated that following intravenous administration to healthy